American Bio Medica Corporation
ABMC
$0.00
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -1.80% | -20.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.80% | -20.10% | |||
| Cost of Revenue | -70.68% | 40.83% | |||
| Gross Profit | 152.86% | -1,455.56% | |||
| SG&A Expenses | 12.17% | -0.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.74% | 18.68% | |||
| Operating Income | 45.92% | -49.62% | |||
| Income Before Tax | 693.38% | -0.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 693.38% | -0.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 693.38% | -0.96% | |||
| EBIT | 45.92% | -49.62% | |||
| EBITDA | 46.17% | -51.60% | |||
| EPS Basic | 692.42% | -1.54% | |||
| Normalized Basic EPS | 26.83% | 0.00% | |||
| EPS Diluted | 515.96% | 6.00% | |||
| Normalized Diluted EPS | 26.83% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||